Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

ClinicalTrials.gov ID: NCT05596734

Public ClinicalTrials.gov record NCT05596734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1/2 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED MODIFIED RNA VACCINE CANDIDATES AGAINST COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Substudy A: This is a Phase 1 randomized, open-label study to describe the safety and immunogenicity of up to 3 dose- level combinations of modRNA quadrivalent influenza vaccine (qIRV (22/23)) and bivalent BNT162b2 (original/Omi BA.4/BA.5). Participants will receive either: * qIRV (22/23)/bivalent BNT162b2 (original/Omi BA.4/BA.5), at 1 of the 3 dose-level combinations * qIRV (22/23) at dose level 1, * qIRV (22/23) at dose level 2, or * bivalent BNT162b2 (original/Omi BA.4/BA.5) at dose level 1 administered concurrently in the opposite arm to commercially licensed quadrivalent influenza vaccine (QIV). Substudy B: This Phase 1/2 study will describe the safety, tolerability, and immunogenicity of quadrivalent influenza vaccine (qIRV)/bivalent BNT162b2 (original/Omi BA.4/BA.5), trivalent influenza vaccine (tIRV)/bivalent BNT162b2 (original/Omi BA.4/BA.5), and bivalent influenza vaccine (bIRV)/bivalent BNT162b2 (original/Omi BA.4/BA.5) when given concurrently with licensed quadrivalent influenza vaccine (QIV).

Study identification

NCT ID
NCT05596734
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
BioNTech SE
Industry
Enrollment
1,019 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2022 (Actual)
Primary completion
Dec 28, 2023 (Actual)
Completion
Dec 28, 2023 (Actual)
Last update posted
Jul 23, 2025

2022 – 2023

United States locations

U.S. sites
59
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
North Alabama Research Center Athens Alabama 35611 —
The Heart Center Athens Alabama 35611 —
HOPE Research Institute Phoenix Arizona 85018 —
The Pain Center of Arizona Phoenix Arizona 85018 —
Orange County Research Center Lake Forest California 92630 —
Orange County Heart Institute Orange California 92868 —
California Research Foundation San Diego California 92123 —
Orange County Research Center Tustin California 92780 —
Proactive Clinical Research,LLC Fort Lauderdale Florida 33308 —
Finlay Medical Research Greenacres City Florida 33467 —
Indago Research & Health Center, Inc Hialeah Florida 33012 —
Research Centers of America ( Hollywood ) Hollywood Florida 33024 —
Angels Clinical Research Institute Miami Florida 33122 —
Miami Clinical Research Miami Florida 33155 —
Gerardo Polanco, MD Miami Florida 33156 —
Research Institute of South Florida Miami Florida 33173 —
Entrust Clinical Research Miami Florida 33176 —
Jackson Medical Group Cardiac Care Miami Florida 33176 —
Miami Dade Medical Research Institute, LLC Miami Florida 33176 —
Palm Springs Community Health Center Miami Lakes Florida 33014 —
Panax Clinical Research Miami Lakes Florida 33014 —
Palm Springs Community Health Center Miami Lakes Florida 33016 —
Innovation Medical Research Center Palmetto Bay Florida 33157 —
DBC Research USA Pembroke Pines Florida 33029 —
United Medical Research Port Orange Florida 32127 —
Velocity Clinical Research, Savannah Savannah Georgia 31406 —
Savannah Medical Group Savannah Georgia 31419 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Great Lakes Clinical Trials - Ravenswood Chicago Illinois 60640 —
Retina Associates Elmhurst Illinois 60126 —
Affinity Health Oak Brook Illinois 60523 —
Alliance for Multispecialty Research, LLC Oak Brook Illinois 60523 —
Alliance for Multispecialty Research, LLC Wichita Kansas 67207 —
Jadestone Clinical Research Silver Spring Maryland 20904 —
Michigan Center of Medical Research (MICHMER) Farmington Hills Michigan 48334 —
Pradeep Chandra, DO, FACC Bridgeton Missouri 63044 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Sundance Clinical Research St Louis Missouri 63141 —
Pioneer Heart Institute Lincoln Nebraska 68506 —
Quality Clinical Research Omaha Nebraska 68114 —
Velocity Clinical Research, Omaha Omaha Nebraska 68134 —
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801 —
SUNY Upstate Medical University Institute for Global Health Syracuse New York 13215 —
Monroe Biomedical Research Monroe North Carolina 28112 —
M3 Wake Research, Inc. Raleigh North Carolina 27612 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Velocity Clinical Research, Providence East Greenwich Rhode Island 02818 —
Main Street Physician's Care Little River South Carolina 29566 —
McLeod Cardiology Associates - Little River Little River South Carolina 29566 —
Alliance for Multispecialty Research, LLC Knoxville Tennessee 37909 —
Alliance for Multispecialty Research, LLC Knoxville Tennessee 37920 —
University of Texas Medical Branch Galveston Texas 77555 —
Prolato Clinical Research Center Houston Texas 77054 —
DM Clinical Research, Martin Diagnostic Clinic Tomball Texas 77375 —
DM Clinical Research Tomball Texas 77375 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05596734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05596734 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →